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Selective delivery of antiparasitic or antibacterial drugs into infected macrophages could be a promising
approach for improved therapies. Methotrexate conjugate with branched chain polypeptides exhibited
pronounced anti-Leishmania activity in vitro and in vivo as reported here earlier. To identify structural
requirements for efficient uptake of branched polypeptides, we have studied murine bone marrow
culture-derived macrophages (BMM) from 129/ICR mice. We report on the translocation character-
istics of structurally closely related compounds labeled with 5(6)-carboxyfluorescein. We found that
this process is dependent on experimental conditions (e.g. polypeptide concentration, incubation time,
and temperature). Using specific inhibitors as well as macrophages from wild-type and class-A
scavenger receptor knockout (SR-A -/-) mice, we demonstrated that SR-A was involved in the
endocytosis of some polypeptides depending on their charge. Uptake could be blocked by unlabeled
polypeptide, by SR-A inhibitors, and by specific anti-SR-A monoclonal antibody. The polyanionic
polypeptide poly[Lys(Succ-Glu1.0-DL-Ala3.8)] (SuccEAK) with high charge density translocated more
efficiently than poly[Lys(Ac-Glu1.0-DL-Ala3.8)] (AcEAK), which had a lower anionic charge density. On
the basis of experimental data presented, SuccEAK can be considered as a potential candidate for the
design of a macromolecular carrier for specific drug delivery of bioactive entities into macrophages
via SR-A.
INTRODUCTION
A number of intracellular pathogens including Myco-
bacterium tuberculosis (1) and the unicellular parasite
Leishmania (2) are capable of surviving intracellularly
in macrophages within phagosomes. Macrophage-selec-
tive delivery of antibacterial or antiparasitic drugs by
endocytosis via specific receptors could be an attractive
strategy for more efficient therapies. This approach would
require the development of therapeutic macrophage
receptor-specific carriers of macromolecular nature. Scav-
enger receptors play a crucial role in the uptake of
bacteria (3, 4), apoptotic cells, and modified lipoproteins
(5). Scavenger receptors are structurally varied trans-
membrane proteins binding mainly polyanions with
diverse chemical composition (e.g. sulfated polysaccha-
rides, poly(I) and poly(G)) (6). Reports published earlier
described successful introduction of antimycobacterial
p-aminosalicylic acid (7) and phthalocyanine derivatives
(8) into macrophages or macrophage cell lines by using
maleylated BSA (mal-BSA). The conjugate of p-ami-
nosalicylic acid was taken up by peritoneal macrophages
infected in culture by M. tuberculosis and was 100 times
more effective in killing the intracellular organisms
(7). J774 macrophages treated with the conjugate of
phthalocyanine derivatives with mal-BSA exhibited pho-
totoxicity higher than in nonphagocytic EMT-6 cells (8).
Mukhopadhyay et al. found that daunomycin coupled to
mal-BSA entered daunomycin resistant J774A.1 cells (9)
in vitro. When injected into mice, the daunomycin-mal-
BSA conjugate was cleared rapidly from the circulation
and accumulated in the macrophage-rich tissues, liver,
lung, and spleen (10). The same group described also that
the conjugate of methotrexate and mal-BSA delivered the
drug into Leishmania donovani-infected macrophages
(11). Also, Prasad and colleagues coupled antisense
oligonucleotide to a 10-mer poly(G) and introduced this
into the J774E macrophage cell line (12).
Very few systematic studies have been reported on
structural and functional factors required for delivery/
targeting of bioactive entities by macromolecules. To this
end we have initiated systematic structure-function
studies for rational selection of polypeptides as synthetic
macromolecular carriers. For this we prepared several
groups of branched chain polypeptides with the general
formula of poly[Lys(Xi-DL-Alam)] (XAK) (Figure 1), where
i = 1, m = 3-4, and X represents an additional optically
active amino acid residue (13, 14). These polypeptides
characterized by chemical (primary structure, conforma-
tion) and biological (in vitro cytotoxicity, biodegradation,
immunoreactivity, and biodistribution) properties (13-
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15) had a marked effect on phospholipid model mem-
branes depending on their side chain structure (16-18).
Recently we prepared several highly active bioconju-
gates in which an antitumor agent (19), radionucleide
(20), or epitope peptide (21) was covalently attached to
selected branched polypeptides.The coupling of an acid
labile derivative of daunomycin to poly[Lys(Glui-DL-
Alam)] (EAK) resulted in compensation of the immuno-
suppressive effect of the drug, and this conjugate in vivo
was very effective in mice bearing L1210 leukemia
producing 66-100% long-term (>60 days) survivors (22).
Recently, a pronounced anti-Leishmania donovani effect
of methotrexate (MTX) branched polypeptide conjugates
was observed in vitro and in vivo (23). We demonstrated
that the leishmanicidal activity was carrier dependent
and the covalent bond between the carrier and MTX is
essential. On the basis of in vitro observations, we
postulated that the MTX conjugate exhibited an effect
through uptake by macrophages, which was different
from that of the free drug.
The aim of this work was to analyze the uptake of
structurally related branched polypeptides by murine
bone marrow culture-derived macrophages (BMM) from
129/ICR mice. We found that polypeptides labeled with
5(6)-carboxyfluorescein are taken up and that the process
was dependent on experimental conditions (e.g. polypep-
tide concentration, incubation time, and temperature).
Furthermore, comparing polypeptide uptake by wild-type
and class A macrophage scavenger receptor (SR-A)-
deficient macrophages, we demonstrated that SR-A
played a crucial role in the uptake of some of the
polypeptides tested. SR-A-dependent recognition and
endocytosis of the polypeptides was dependent on their
charge properties. Taken together, our data indicate
that the polypeptide poly[Lys(Succ-Glu1.0-DL-Ala3.8)]
(SuccEAK) could be a potential candidate for the design
of a macromolecular carrier for specific drug delivery of
bioactive entities into macrophages via SR-A.
EXPERIMENTAL PROCEDURES
Abbreviations. Abbreviations of amino acids and
their derivatives follow the revised recommendation of
the IUPAC-IUB Committee on Biochemical Nomencla-
ture entitled “Nomenclature and Symbolism for Amino
Acids and Peptides” (recommendations of 1983). Nomen-
clature of branched chain polypeptides was used in
accordance with the recommended nomenclature of graft
polymers (24). For the sake of brevity, codes of branched
chain polypeptides were constructed by us using the one-
letter codes of amino acids. All amino acids are L
configuration unless otherwise stated. The other ab-
breviations in this paper are the following: Z: benzyl-
oxycarbonyl, Boc: tert-butyloxycarbonyl, Pcp: pentachlo-
rophenyl, NCA: N-carboxy anhydride, HOBt: 1-hydroxy-
benzotriazole, DMF: N,N-dimethylformamide, DMSO:
dimethyl sulfoxide, TEA: triethylamine, DCM: dichlo-
romethane, NMM: 4-methylmorpholine, TEA: triethyl-
amine, TFA: trifluoracetic acid PBS: phosphate-buffered
saline, Ac: acetyl, Succ: succinyl, Mal: maleyl, CF: 5(6)-
carboxyfluorescein, DiI: 1,1′-dioctadecyl-1-3,3,3′,3′-tet-
ramethylindocarbocyanine perchlorate, LDL: low-density
lipoprotein.
Branched Chain Polypeptides. Reagents and Sol-
vents. Amino acids used for this study, HCl, trifluoracetic
acid, acetic acid anhydride, and succinic anhydride, were
purchased from REANAL (Budapest, Hungary). Benzyl-
oxycarbonyl chloride, pentachlorophenol, N,N′-dicyclo-
hexylcarbodiimide, HOBt, TEA, DMSO, and NMM were
from Fluka (Buchs, Switzerland). Acetonitrile was from
Merck (Darmstadt, Germany). 5(6)-Carboxyfluorescein
succinimide ester was obtained from Sigma-Aldrich
(Budapest, Hungary).
Synthesis of Poly[Lys]âHBr. The synthesis was carried
out from NR-carboxy-N-benzyloxycarbonyl-lysine anhy-
dride under conditions to obtain an average degree of
polymerization of approximately 100 (monomer: diethyl-
amine initiator molar ratio ) 50:1), as reported previ-
ously (25). Protecting groups were cleaved by HBr in
glacial acetic acid (35%, m/V) and poly[Lys]âHBr was
precipitated using diethyl ether. The polypeptide was
purified by dialysis against distilled water using visking
casing and was isolated by freeze-drying. The average
relative molar masses (Mw, Mz) were determined by
sedimentation equilibrium using a short column tech-
nique at 25 °C (MOM 3180 type analytical ultracentri-
fuge, Hungary). The number average of the relative
molar mass (Mn), the polydispersity factor (Mz/Mw), and
the average degree of polymerization (DPn) values were
calculated from data described earlier (26).
Synthesis of Poly[Lys(Xi-DL-Alam)] (XAK) Type Polypep-
tides and the Polyanionic Derivatives of Poly[Lys(Glui-
DL-Alam)], (EAK). Poly[Lys(DL-Alam)] (AK) (27) and poly-
[Lys(Xi-DL-Alam)] (XAK) polypeptides, where X ) Glu or
Ser, were prepared as described earlier (28). Briefly, AK
polypeptide was synthesized by grafting short oligomeric
DL-Ala chains to the NH2 group of lysine residues using
N-carboxy-DL-Ala-anhydride. The terminal amino acids
(X) were coupled to the RNH2-groups of the side chains
as Z-X-OPcp, where X ) Glu or Ser. The reaction was
performed by an in situ active ester method using an
equivalent amount of HOBt dissolved in DMF as activat-
ing reagent. The pH of the solution was adjusted to 8.0
by adding NMM. Stirring was continued at room-tem-
perature overnight. Z-protecting groups were removed
with HBr using acetic acid containing 35% HBr. The
polypeptides were purified by dialysis against distilled
water for 2 days using a Visking tube (cutoff ) 12000-
14000 Da) and isolated by freeze-drying.
Poly[Lys(AcGlui-DL-Alam)] (AcEAK) was prepared by
acetylation of poly[Lys(Glui-DL-Alam)] (EAK) as follows.
85 mg (159 ímol) of EAK was dissolved in 2 mL of
distilled water and diluted with 10 mL of DMF under
cooling at 0 °C. 27 íL (198 ímol) of TEA was added to
this solution to neutralize the polymer. Five equivalents
of freshly prepared imidazolyl-acetate was used for the
acetylation (29), and then the product was dialyzed
against distilled water followed by freeze-drying.
Figure 1. Chemical structure of the amphoteric EAK and its
polyanionic derivatives.
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Poly[Lys(Succ-Glui-DL-Alam)] (SuccEAK) was prepared
by succinylation and poly[Lys(Mal-Glui-DL-Alam)] (MalE-
AK) by maleylation of poly[Lys(Glui-DL-Alam)],(EAK) as
follows. 10 mg (18.5 ímol) EAK) was dissolved in 2 mL
of 0.1 M carbonate buffer (pH ) 9.2). 220 íL (220 mmol)
of succinic anhydride or 219 íL (220 mmol) maleic
anhydride, respectively, was dissolved in DMSO (c ) 100
mg/mL) and was added to this solution with continuous
stirring for 30 min at RT (30). The pH was maintained
between 9.0 and 9.2 with 0.1 M NaOH. The reaction was
continued for 4 h followed by dialysis against distilled
water for 2 days and then freeze-drying.
Amino Acid Analysis. The amino acid composition of
the polymeric polypeptides was determined by amino acid
analysis using a Beckman 6300 analyzer (Fullerton, CA).
Prior to analysis, the samples were hydrolyzed in 6 M
HCl in sealed and evacuated tubes at 105 °C for 24 h.
Labeling of Branched Polypeptides with 5(6)-Carboxy-
fluorescein. 10 mg (6  10-7 to 1.9  10-7 mol) amounts
of polypeptides were dissolved in 2 mL of Na2CO3 buffer
(0.1 M; pH 9.4). The amino-reactive dye 5(6)-carboxy-
fluorescein succinimide ester (5(6)-CF-SE) was dissolved
in DMF (c ) 10 mg/mL, 0.21 mM) and was added to the
polypeptide solution in 20 íL aliquots. The reaction was
continued for 1 h at room temperature with continuous
stirring. The product was purified on a PD10 Sephadex
G25 column using distilled water as eluent. The samples
were then freeze-dried and they were resolved in PBS
(0.1 M, pH 7.4) before use.
Determination of 5(6)-Carboxyfluorescein Con-
tent of Conjugates. Labeled polypeptide samples and
5(6)-carboxyfluorescein succinimide ester were hydro-
lyzed in 6 M HCl in sealed and evacuated tubes at 110
°C for 24 h. HCl was removed, and the hydrolysate was
dissolved in DMSO. The hydrolyzed samples (20 íL) were
analyzed by RP-HPLC using reversed phase Eurospher
C18 column (3.9  250 mm; packed with spherical 5 ím
silica with 100 Å pore size [Knauer, Bad Homburg,
Germany] and gradient elution consisted of 0.1% TFA
in water [eluent A] and 0.1% TFA in acetonitrile/water
) 80/20 v/v [eluent B]). During chromatography the
eluent B content was between 25 and 45%, in 20 min,
45-99%, in 10 min. The flow rate was 1 mL/min at room
temperature. The average sample concentration applied
was 0.65 íg/mL. Peaks were detected at ìex ) 419 nm
and ìem ) 519 nm using a fluorescence detector (Shi-
madzu, Japan). A calibration curve was constructed using
5(6)-carcoxyfluorescein in the 4.8  10-5 M to 1.2  10-5
M concentration range.
Functional Studies. Reagents. 1,1′-Dioctadecyl-1-
3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)-
labeled acetylated LDL (DiI-AcLDL) was obtained from
Autogen Bioclear, and poly(I) from Signa (Reading, UK).
OptiMEM medium and all other culture media were from
Invitrogen (Paisley, United Kingdom). Rat anti-mouse
SR-A antibody 2F8 was prepared at the Sir William
Dunn School of Pathology, Oxford, as described previ-
ously (33). CAMPATH rat anti-mouse IgG, an isotype-
control for 2F8, was a kind gift from H. Waldmann, Sir
William Dunn School of Pathology, Oxford. Cy3-labeled
donkey anti-rat IgG was from Jackson ImmunoResearch
(Soham, UK), and rabbit and goat sera were from Sigma.
Fluorescent Mounting Medium was from DakoCytoma-
tion (Glostrup, Denmark). Plastic products were pur-
chased from Becton Dickinson Labware (Oxford, UK).
Animals. Mice deficient in SR-AI and II (SR-A -/-)
were produced as previously described (31). SR-A -/-
and SR-A +/+ control 129/ICR mice of the same sex were
used at 8-12 weeks of age. All animals were handled in
accordance with guidelines issued by the Home Office,
United Kingdom.
Cell Isolation and Culture. BMM were obtained and
cultured by standard procedures described previously (4).
The cells were maintained in 15 cm bacteriologic plastic
(BP) Petri dishes containing RPMI 1640 with 50 IU/mL
penicillin G, 50 íg/mL streptomycin, 2 mM glutamine
(PSG), 10% fetal calf serum (FCS), and 15% (vol/vol)
L-cell conditioned medium (LCM) as a source of mac-
rophage colony-stimulating factor (32). The macrophages
were harvested with PBS (0.1 M, pH 7.4) containing 10
mM EDTA and 4 mg/mL lidocaineâHCl and plated onto
six-well BP plates (Greiner, Gloucester, United King-
dom). The cells were maintained in the six-well plate for
further 24 h at 37 °C. The bone marrow from the femurs
and tibias of one mouse gave (1-5)  107 M after 7 days
in culture.
Cytotoxicity Assay. Prior to the experiment, cells were
washed three times with PBS. Each polypeptide was
added in OptiMEM at a concentration of 1 íg/mL or 20
íg/mL. BMM were incubated with the polypeptide
solution for 1 h and then harvested with lidocaine/EDTA.
The number of living cells was determined by counting
the cells in a Neubauer haemocytometer after staining
with 0.4% trypan blue dissolved in PBS. The statistical
significance of data was determined by Student’s t test
at the 95% confidence level.
Flow Cytometry Analysis of Cellular Uptake. Polypep-
tides labeled with 5(6)-CF dissolved in OptiMEM were
used. Before adding CF-labeled polypeptides, the cells
were washed three times with PBS. The CF-labeled
polypeptides were incubated with the cells for 1 h at 37
°C or 4 °C. For the inhibition experiments poly(I) at 50
íg/mL (4) or 2F8 at 15 íg/mL was used (33). Prior to the
addition of polypeptides, cells were preincubated for 30
min with inhibitor which was also maintained through-
out the experiment. In some experiments unlabeled
polypeptides were added at 10 times excess of labeled
molecule concentration. The increase in macrophage
fluorescence following incubation with labeled molecules
was analyzed by flow cytometry. Data were analyzed with
CellQuest 3.0 software. The mean fluorescence of un-
treated control cells was subtracted from the mean
fluorescence obtained with treated samples under all
different assay conditions applied. Statistical analysis of
data was performed using Student’s t test at the 95%
confidence level.
Analysis of the Cellular Uptake by Confocal Microscopy.
Wild-type 129/ICR BMM were plated on sterile glass
coverslips in 24-well tissue-culture dishes in RPMI 1640
medium supplemented PSG; 10% FCS; and 15% (vol/vol)
LCM at 5  104 macrophages per well 24 h prior to the
experiment. The cells were washed three times with PBS.
CF-labeled polypeptides were incubated with the cells for
5, 15, 30, and 60 min at 37 °C. Cells were fixed with 4%
formaldehyde/PBS for 15 min at room temperature then
permeabilized using a blocking buffer containing 1% (m/
V) BSA, 0.25% (m/V) saponin, and 1% goat and 1% rabbit
serum. The cells were incubated with 2F8 (c ) 10 íg/
mL) or with an isotype-matched control antibody (CAM-
PATH 1G) in parallel for 1 h at room temperature
followed by washing three times with blocking buffer.
After incubation with Cy3 labeled anti-rat IgG antibody
for 1 h in the dark, the coverslips were mounted on glass
microscopy slides using DakoCytomation Fluorescent
Mounting Medium. Cells were analyzed in a BIO RAD
Radiance 2000 confocal microscope (ìex ) 488 nm).
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RESULTS
Branched Polypeptides. Branched polypeptides with
the general formula poly[Lys(Xi-DL-Alam)], (m = 4, i =
1), which were used for these studies have short oligo-
(DL-Ala) side chains and Glu at the N-terminal of the
branches. The terminal amino acid X was coupled to the
RNH2 groups of the terminal alanine by an in situ active
ester method (28). EAK bearing RNH2 and also free
carboxyl groups at the end of the branches possess an
amphoteric character. The three additional polypeptides
that were also included in our studies were the polyan-
ionic derivatives of poly[Lys(Glu1.0-DL-Ala3.8)] (EAK) pre-
pared by acetylation, succinylation or maleylation of the
RNH2 groups of the terminal glutamic acid residues
(Figure 1). Poly[Lys(AcGlu1.0-DL-Ala3.8)] (AcEAK) side
chains contain only one negative charge per monomer
unit under conditions used for the present studies. The
charge density of the succinylated (poly[Lys(SuccGlu1.0-
DL-Ala3.8)], SuccEAK) and maleylated (poly[Lys(Mal-
Glu1.0-DL-Ala3.8)], MalEAK) polypeptides were higher,
since two negative charges were present per unit. Thus,
we investigated this group of structurally related polypep-
tides built on a polylysine backbone with systematically
altered chemical properties (charge, conformation (13,
30)). The polypeptides were characterized according to
their relative average molar mass, determined by sedi-
mentation equilibrium analysis (26), and the composition
of their side chain. The chemical characteristics of the
polypeptides are shown in Table 1.
Cytotoxic Effect of Polypeptides on BMM. The
cytotoxicity of polypeptides labeled with CF was studied
on BMM cells from wild-type mice at two different
concentrations (1 íg/mL and 20 íg/mL). The cytotoxicity
of the polypeptides was determined by counting live cells
by trypane blue exclusion. Polylysine was included as a
control. Results are expressed as a percentage of un-
treated cells and summarized in Figure 2. We found that
after 1 h incubation none of the polypeptides had a
significant toxic effect on the macrophages at 1 íg/mL
concentration. At 20 íg/mL poly[Lys] proved to be highly
toxic, but no cytotoxic effect of the other polypeptides was
observed.
Uptake of polypeptides by BMM. We studied the
endocytosis of polypeptides by BMM from wild-type mice
under different conditions. The effects of polypeptide
concentration, incubation time, and temperature on
uptake were analyzed. Furthermore we investigated the
influence of unlabeled polypeptides on the internalization
of CF-polypeptides in inhibition assays.
Influence of the Polypeptide Concentration on
the Uptake. BMM from wild-type mice were incubated
with varying concentrations (0.1-100 íg/mL) of the CF-
labeled polypeptides, and the rate of uptake was detected
by flow cytometry. The amphoteric EAK and polyanionic
AcEAK were internalized only at 100 íg/mL concentra-
tion. In the case of polyanionic SuccEAK, uptake was
proportional with the increasing concentration in the
concentration range tested, while MalEAK was taken up
effectively only at 50 and 100 íg/mL (Figure 3).
Time Dependence. Time dependence of uptake was
examined by flow cytometry after 1, 5, 10, 20, 30, 45, and
60 min incubation with the polypeptides (Figure 4). The
internalization of the polyanionic polypeptides by the
cells was in direct proportion to the duration of incuba-
tion. The uptake of neither the scavenger receptor ligand
DiI-AcLDL (c ) 5 íg/mL) used as positive control (6, 34)
nor the CF-polypeptides was saturable during the 1 h
Table 1. Characteristics of Polylysine Based Branched Chain Polymeric Polypeptides with Poly[Lys(Xi-DL-Alam)]
Formula
amino acid compositionb
polypeptide codea Lys Ala (m) X (i) DPnc Mwd ( 5% CF [%]e
poly[Lys] - 1.00 - - 130 16700 -
poly[Lys(Glui-DL-Alam)] EAK 1.00 3.80 1.00 60 31600 2.91
poly[Lys(Ac-Glui-DL-Alam)] AcEAK 1.00 3.80 1.00 60 34500 0.46
poly[Lys(Succ-Glui-DL-Alam)] SuccEAK 1.00 3.80 1.00 60 37900 0.53
poly[Lys(Succ-Glui-DL-Alam)] MalEAK 1.00 3.80 1.00 60 37800 0.72
a Code of branched chain polymeric polypeptides, based on one-letter symbol of amino acids. b Amino acid composition was determined
by amino acid analysis as after hydrolysis in 6 M HCl at 105 °C for 24 h. c Number of average degree of polymerization determined by
sedimentation equilibrium measurements. d Average molecular mass of polymers; calculated from the average degree of polymerization
(DPn) of poly[Lys] and of the side chain composition. e Average degree of substitution for 5(6)-carboxyfluorescein (CF) was determined by
reverse phase HPLC after hydrolysis of the samples in 6 M HCl at 105 °C for 24 h.
Figure 2. The effect of the branched CF-polypeptides on the
survival of BMM. Columns represent the number of living cells
as a percentage of untreated control ( SD. Polylysine (DPn )
130, Mw ) 17000) was used as control polypeptide. 9: c ) 1
íg/mL, 0: c ) 20 íg/mL. Statistical analysis of data was
performed by Student’s t test; *: p<0.05. Poly[L-Lys] (Mw )
17000, DPn ) 130) was used as control.
Figure 3. Concentration dependence of the uptake of the CF-
polypeptides by BMM after 60 min incubation with the
polypeptides. Symbols represent the average of mean fluores-
cence values of a representative experiment of three indepen-
dent assays ( SD after subtracting the control. 9: CF-EAK, O:
CF-AcEAK, 2: CF-SuccEAK, 3: CF-MalEAK.
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study period, and the polyanionic polypeptides were
taken up continuously by the BMM during this time
(Figure 4).
Temperature Dependence. The uptake of the poly-
peptides was also investigated at 4 °C versus 37 °C by
flow cytometry. The results are summarized in Figure
5. In the case of the amphoteric EAK no significant
uptake could be observed at 37 °C or 4 °C. Two polyan-
ionic polypeptides, AcEAK and SuccEAK, were internal-
ized only at 37 °C. In the case of MalEAK a significant
difference could be observed between the uptake at 4 °C
or at 37 °C.
The Effect of Pretreatment with Unlabeled Poly-
peptides. In this experiment the endocytosis of CF-
SuccEAK was examined at the lowest concentration that
could be easily detected. Macrophages were pretreated
with unlabeled polypeptides at a concentration 10 times
higher than the labeled polypeptide for 30 min prior to
the incubation of the cells with the respective CF-
polypeptides. The polyanionic polypeptides, AcEAK and
SuccEAK, significantly inhibited the uptake of the la-
beled SuccEAK into the macrophages (Figure 6). Pre-
treatment of the macrophages with c ) 10 íg/mL
unlabeled SuccEAK inhibited the uptake of CF-SuccEAK
(c ) 1 íg/mL) to the control levels. After 60 min
incubation with the labeled polypeptide, mean fluores-
cence was 1.43 ( 0.15 in the presence and 10.77 ( 0.65
in the absence of the unlabeled SuccEAK, p < 0.01. To a
lesser extent, unlabeled AcEAK also elicited a statisti-
cally significant inhibition of the internalization of CF-
SuccEAK (mean fluorescence [%] ) 7.36 ( 0.31 in the
presence of AcEAK, p < 0.01).
The Role of the Scavenger Receptor in the Up-
take of Polyanionic Polypeptides. To clarify the
potential involvement of the SR-A, we examined the
uptake of the polypeptides by BMM from SRA -/- mice.
In these studies in order to block the receptor we utilized
a known general SR-A ligand, poly(I), and a specific anti-
SR-A monoclonal antibody, 2F8.
Uptake of Polypeptides by Wild-Type and SR-A
-/- Macrophages. The uptake of polyanionic polypep-
tides CF-AcEAK, CF-SuccEAK, and CF-MalEAK was
tested. The scavenger receptor ligand DiI-AcLDL was
used as a positive control (34), and the amphoteric CF-
EAK polypeptide as negative control. The three polyan-
ionic polypeptides were internalized by wild-type mac-
rophages, but to a lower extent compared with DiI-
AcLDL (Figures7 and 8). The uptake of CF-SuccEAK,
with higher negative charge density, by wild-type BMM
was greater than CF-AcEAK having less negative charges
and CF-MalEAK containing a double bond in its anionic
end-group. In all cases we observed that the internaliza-
tion of these polypeptides was significantly diminished
in SR-A -/- cells (Figure 7). In the case of CF-SuccEAK
(c ) 50 íg/mL) we detected a thirteen-fold difference
between the fluorescence intensities of the internalized
polypeptide by the wild-type and SRA -/- BMM (mean
fluorescence ) 52.49 ( 1.34 and 3.77 ( 0.01 respectively,
p < 0.001). With CF-AcEAK (c ) 100 íg/mL) a statisti-
cally significant difference could be demonstrated be-
tween the uptake of the wild-type and of the SR-A -/-
macrophages, a 8-fold decrease in the uptake could be
observed (mean fluorescence ) 10.195 ( 1.43 for the wild-
type and 1.235 ( 0.26 for the SRA -/- cells, p < 0.001)
(Figure 8).
Blocking of Scavenger Receptor-A with Poly(I)
and MAb 2F8. Next, wild-type and SR-A -/- BMM
were pretreated with the scavenger receptor ligand poly-
(I) (c ) 50 íg/mL) (4, 6) or the SR-A specific monoclonal
antibody 2F8 (at c ) 15 íg/mL) for 30 min before the
addition of the polypeptides. Data are presented in Figure
8. We observed that the presence of these SR-A scavenger
receptor ligands significantly reduced the uptake of the
Figure 4. Time dependence of the endocytosis of polypeptides.
Symbols represent the average of mean fluorescence values of
a representative experiment of three independent assays ( SD
after subtracting the control. 9: CF-EAK, c )100 íg/mL; O: CF-
AcEAK, c ) 100 íg/mL; 2: CF-SuccEAK, c ) 50 íg/mL; 3: CF-
MalEAK, c ) 100 íg/mL. Insert: time dependence of the uptake
of DiI-AcLDL (c ) 5 íg/mL) under the same conditions.
Figure 5. Uptake of polypeptides by 129/ICR BMM at 4 °C
and 37 °C after 1 h. Columns represent the average of mean
fluorescence values of a representative experiment of three
independent assays ( SD after subtracting the control. 9: 37
°C íg/mL, 0: 4 °C. Statistical analysis of data was performed
by Student’s t test; *: p < 0.05.
Figure 6. Effect of pretreatment with unlabeled polypeptides
of similar chemical character. Symbols represent the average
of mean fluorescence values of a representative experiment of
three independent assays ( SD after subtracting the control.
9: uptake of CF-SuccEAK, c ) 1 íg/mL; b: uptake of CF-
SuccEAK pretreated with unlabeled SuccEAK, c ) 10 íg/mL,
2: uptake of CF-SuccEAK pretreated with unlabeled AcEAK,
c ) 10 íg/mL.
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polyanionic polypeptides and of DiI-AcLDL used as
positive control.
Colocalization of SR-A and CF-polypeptides in
the Cells. The time-dependence of the uptake of CF-
SuccEAK and its colocalization with SR-A were further
investigated by confocal microscopy. We detected SR-A
in cells, using 2F8- and Cy3-labeled anti-rat IgG second-
ary antibody. We found that CF-SuccEAK was internal-
ized by the cells. Vesicles containing the polypeptide were
observed in the cytoplasm (Figure 9). We detected colo-
calization of CF-SuccEAK (green) and SR-A (red) within
5 min of incubation.
DISCUSSION
Class A scavenger receptors are membrane glycopro-
teins that are present mainly on cells of the macrophage
lineage (35). Therefore these receptors are potential
targets for macrophage-specific delivery of macromol-
ecules and their drug or epitope conjugates. The scav-
enger receptor ligands described in the literature are
polyanionic compounds with diverse chemical structure
and composition (e.g. sulfated polysaccharides such as
fucoidin, AcLDL, maleylated proteins, poly(I), and poly(G)
(6).
The present studies are the first attempt at systematic
examination of the interaction between SR-A-bearing
cells and a chemically related polypeptide family with
different charge and structure. Our previous results with
these polypeptides imply that chemical structure, the
charge and length of the side chains, have a pronounced
effect on various biological and physicochemical proper-
ties (16, 17). Results presented in this paper indicate that
the uptake of branched polypeptides by murine BMM
depends on the composition of the branches, indicating
the importance of both charge and the structure of the
terminal amino acid derivative. As assessed by the
fluorescence intensity of CF-labeled polypeptides, we
found a significant difference between the rate of uptake
of the polyanionic polypeptides. Although both SuccEAK
and MalEAK contain two carboxyl groups at the end of
the side chain, whereas AcEAK possesses only one in the
terminal glutamic acid, SuccEAK was internalized by
BMM to a greater extent than MalEAK. This observa-
tion could be explained by the presence of a C-C double
bond in MalEAK, which is in conjugation with the C-O
double bond influencing the charged state of the terminal
carboxyl group.
To analyze the mechanism of uptake we performed
inhibition studies with the polypeptide internalized most
efficiently. The translocation of CF-SuccEAK was inves-
tigated in the presence of unlabeled SuccEAK and also
AcEAK. The results of this study showed that unlabeled
SuccEAK markedly inhibited the internalization of the
CF-labeled polypeptide compound, but AcEAK exhibited
only a partial inhibitory effect. These data suggest that
AcEAK and SuccEAK share the same receptor, but
AcEAK binds with lower affinity or that there are
multiple receptors for SuccEAK some of which are
shared.
To clarify if SR-A was involved in the endocytosis, we
investigated the uptake of the polyanionic polypeptides
on wild-type and SR-A -/- BMM. Results show that
SR-A -/- macrophages internalize these compounds at
a substantially lower level compared with wild-type cells.
Blocking of the SR-A with receptor antagonist, poly(I),
or with an anti-SR-A monoclonal antibody, resulted in a
clear reduction in uptake. In addition, confocal micro-
scopic studies provided independent evidence of colocal-
ization of CF-SuccEAK with SR-A soon after internal-
ization into cells. Taken together, these results suggest
that CF-SuccEAK is taken up by SR-A-mediated endocy-
tosis and indicate that the receptor recognizes polyanionic
polypeptides and has an important role in their uptake.
It is known that not all polyanionic molecules are able
to bind SR-A due to the presence of an undetermined
structural requirement for recognition by the receptor.
Using our systematic modification of polylysine, we were
able to demonstrate that we could enhance binding to
SR-A. Thus, the use this approach provides us a powerful
new tool to study SR-A binding in further detailby
structural manipulation of the polylysine to enhance or
reduce binding to the receptor and by modeling how the
changes alter the charge distribution and spatial ar-
rangement.
We showed that SuccEAK had higher accumulation in
macrophages compared to AcEAK. Interestingly, our
previous data on the blood clearance and biodistribution
of branched polypeptides showed that AcEAK had pro-
longed blood survival in Balb/c mice, while SuccEAK was
cleared rapidly from the circulation (36). This difference
in the blood clearance, which was not due to enzymatic
degradation, could be related to the difference of mac-
rophage uptake between AcEAK and SuccEAK. Thus, the
enhanced uptake by macrophages, mainly through SR-
A, could contribute to the rapid clearance of SuccEAK.
Several previous papers have reported on the uptake
of modified proteins and conjugates by macrophages.
Majumdar et al. demonstrated that the binding of PAS-
MalBSA labeled with 125I to peritoneal macrophages was
saturable, indicating a limited number of binding sites.
Addition of unlabeled conjugate to medium of the mac-
rophages eliminated binding of the labeled compound.
Figure 7. Uptake of polyanionic polypeptides by wild-type and
SR-A -/- BMM. Cells were fixed with 2% formaldehyde.
Diagrams were recorded by measurig 10000 cells. Data were
analyzed by CellQuest 3.0. a. Filled diagrams represent wild-
type macrophages, while open lines represent SR-A -/- cells.
(a) DiI-AcLDL, c ) 5 íg/mL, (b) CF-EAK, c ) 100 íg/mL, (c)
CF-AcEAK: c ) 100 íg/mL, (d) CF-SuccEAK, c ) 50 íg/mL, (e)
CF-MalEAK, c ) 50 íg/mL.
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The authors also demonstrated the uptake of the conju-
gate at 37 °C, which was followed by its lysosomal
degradation (7). Brasseur et al. described the specific
uptake of phthalocyanine-malBSA conjugates followed by
photoinactivation of J774 macrophages. The receptor
binding was demonstrated by competition assay between
labeled and nonlabeled conjugates (8). These studies
showed no direct evidence of the involvement of scaven-
ger receptors in the processes described. Similarly, the
articles of Mukhopadhyay et al. contained no experimen-
tal data on the involvement of scavenger receptors in the
uptake and cytotoxicity of daunomycin or methotrexate
conjugates with mal-BSA (9-12). Recognition of a 10-
mer poly(G)-tethered antisense oligonucleotide by scav-
enger receptors was assessed by a competition assay. In
this the degradation of 125I-labeled mal-BSA by J774E
Figure 8. Uptake of polyanionic polypeptides by wild-type and SR-A -/- BMM, CF-AcEAK: c ) 100 íg/mL. CF-SuccEAK, c ) 50
íg/mL,MalEAK, c ) 50 íg/mL DiI-AcLDL, c ) 5 íg/mL. Columns represent the average of mean fluorescence values of a representative
experiment of three independent assays ( SD after subtracting the control. 9: 129/ICR, gray: SR-A -/-.
Figure 9. Colocalization of SR-A (red) and CF-SuccEAK (green). SR-A was detected by the SR-A specific monoclonal antibody 2F8
and a Cy3-labeled secondary antibody. The cells were analyzed by confocal microscopy (ìex ) 488 nm). (a) isotype control of 2F8, (b)
CF-SuccEAK 5 min, (c) CF-SuccEAK 15 min, (d) CF-SuccEAK 30 min, (e) CF-SuccEAK 60 min, (f) control cells not reated with
polypeptide, SR-A detected by 2F8 and a Cy3 labeled secondary antibody, (g) CF-SuccEAK 5 min and SR-A: merge, (h) CF-SuccEAK
15 min and SR-A: merge, (i) CF-SuccEAK 30 min and SR-A: merge, (j) CF-SuccEAK 60 min and SR-A: merge. Arrows show examples
of colocalization.
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cells in the presence or absence of different polyanionic
molecules as competitors exhibited the characteristic
scavenger receptor profile (12).
To the best of our knowledge this is the first report to
show that systematic chemical modification of polylysine-
based polypeptides greatly influences the rate and mech-
anism of uptake by BMM. We also demonstrated for the
first time that the internalization of polyanionic synthetic
polypeptides, especially SuccEAK, could be considered a
SR-A mediated process. Thus, this polypeptide seems to
be appropriate as a macromolecular carrier for specific
drug delivery into macrophages and they can become the
basis for development of further carrier molecules and
bioconjugates.
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